Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 Negotiations to resolve the Oxbryta recall lawsuit will begin after the parties present arguments over Pfizer’s motion to dismiss the case this week. July 8, 2025 Irvin Jackson Add Your Comments A federal judge has appointed a mediator to oversee negotiations in an Oxbryta class action lawsuit, in hopes of the parties reaching a settlement agreement to resolve claims over the recalled sickle cell disease treatment before trial gets underway in August 2027. Oxbryta (voxelotor) was first introduced by Global Blood Therapeutics in late 2019, after the medication was granted accelerated approval by the U.S. Food and Drug Administration (FDA). Oxbryta was promoted as the first drug to treat the root cause of sickle cell disease, by improving hemoglobin levels in the body and helping the blood cells retain more oxygen. Pfizer subsequently acquired Global Blood Therapeutics for $5.4 billion in 2022, and continued to promote the treatment as safe and effective. However, following a large number of reports involving users experiencing painful sickle cell complications and deaths due to vaso-occlusive crises (VOC), Pfizer announced a global Oxbryta recall in September 2024, acknowledging that the risks associated with the treatment outweigh any potential benefits. VOCs occur when the red blood cells block blood flow, and the tissues become deprived of oxygen. This can cause an inflammatory response, which can lead to symptoms like pain in the chest, back and limbs, as well as fever. Patients often have to be hospitalized and can suffer kidney failure and stroke. Additionally, many patients die following a vaso-occlusive event. The Oxbryta class action lawsuit was filed in December 2024, seeking damages for former users who were prescribed the treatment since November 1, 2019. In the intervening months, several other Oxbryta lawsuits have been filed by individuals who experienced severe side effects from the recalled drug, but the class action claim seeks damages even for those who have not been injured, claiming that the manufacturers placed a desire for profits over the health and welfare of those with sickle cell disease. Oxbryta Lawsuit Were you prescribed Oxbryta? Oxbryta lawsuits are being filed for sickle cell disease patients who developed vaso-occlusive crises (VOCs), strokes and other side effects caused by recalled Oxbryta. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Oxbryta Lawsuit Were you prescribed Oxbryta? Oxbryta lawsuits are being filed for sickle cell disease patients who developed vaso-occlusive crises (VOCs), strokes and other side effects caused by recalled Oxbryta. Learn More SEE IF YOU QUALIFY FOR COMPENSATION U.S. District Judge Trina Thompson has been assigned to oversee the litigation and scheduled an early trial date in the Oxbryta lawsuit, indicating that the class action claims will go before a jury on August 16, 2027. Following a case management conference held on June 26, Judge Thompson issued a court order (PDF) appointing retired Judge Philip S. Gutierrez to serve as a mediator in the claim, and ordered the parties to begin Oxbryta settlement talks on September 9, 2025. According to a joint statement (PDF) submitted by the parties on June 18, the litigation is still in its early stages, with no discovery process having yet begun. There are at least three similar Oxbryta lawsuits filed in various federal courts, and eight complaints pending in California state court, according to lawyers involved in the class action. The Court is scheduled to hear oral arguments today on a pending motion to dismiss filed by Pfizer. The drug maker maintains that the complaint lacks sufficient factual detail to support allegations of fraud, breach of warranty and deceptive marketing, and that it does not meet the legal standards required to proceed under federal rules. Tags: Oxbryta, Oxbryta Recall, Pfizer, Sickle Cell, Stroke, Vaso-occlusive crises (VOCs) More Oxbryta Stories Wrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises June 5, 2025 Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs May 23, 2025 First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks May 9, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025) Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 5 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITUterine Cancer Cases Expected to ‘Increase Substantially’ Over Next 30 Years: Study (07/08/2025)Hair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 5 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITUterine Cancer Cases Expected to ‘Increase Substantially’ Over Next 30 Years: Study (07/08/2025)Hair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)